Nifurtimox is a nitrofuran antiparasitic agent used primarily to treat Chagas disease and African trypanosomiasis, also known as sleeping sickness. By inhibiting mitochondrial respiration in parasites,… Read more
Nifurtimox is a nitrofuran antiparasitic agent used primarily to treat Chagas disease and African trypanosomiasis, also known as sleeping sickness. By inhibiting mitochondrial respiration in parasites, this medication effectively disrupts their metabolic processes. Analytical laboratories require high-quality reference standards of Nifurtimox to perform rigorous quality control and ensure the efficacy and safety of pharmaceutical products. This category provides access to Nifurtimox API as well as related non-pharmacopeial impurities and stable isotope-labelled compounds, such as Nifurtimox-d4. These specialized materials are essential for conducting precise impurity profiling, supporting accurate quantitative analysis, and facilitating method validation during the drug development process. By utilizing these characterized reference materials, researchers can maintain the accuracy of stability testing and ensure compliance with stringent analytical standards throughout the lifecycle of the drug product.